Showing results (101-110 of 221) with videos related to
Sort By:
Pageof 23
Headache|May 3, 2024
Prevalence and burden of migraine in the United States: A systematic reviewFred Cohen, Caroline V Brooks, Daniel Sun, et al.Frontiers in Pain Research (Lausanne, Switzerland)|December 26, 2025
From randomized controlled trial to real world clinical evidence: effectiveness and engagement of in-home virtual reality pain treatment for chronic pain in older adultsTodd Maddox, Josh Sackman, Emily Judge, et al.Mayo Clinic Proceedings|April 6, 2020
Characterization of Acute Prescription Migraine Medication Use: Results From the CaMEO StudySusan Hutchinson, Richard B Lipton, Jessica Ailani, et al.Headache|January 21, 2026
Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi-source dataset, observational cohort studyDawn C Buse, Lindsay A Videnieks, Karissa Charles, et al.Therapeutic Advances in Neurological Disorders|June 6, 2022
The importance of an early onset of migraine prevention: an evidence-based, hypothesis-driven scoping literature reviewChristopher Gottschalk, Dawn C Buse, Michael J Marmura, et al.Headache|October 5, 2023
Impact of monthly headache days on migraine-related quality of life: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) studyRichard B Lipton, Patricia Pozo-Rosich, Serena L Orr, et al.Headache|August 14, 2019
Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) StudyDawn C Buse, Kristina M Fanning, Michael L Reed, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 12, 2019
Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxietyAndrew M Blumenfeld, Stewart J Tepper, Lawrence D Robbins, et al.Headache|February 18, 2014
Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) StudyRichard B Lipton, Daniel Serrano, Jelena M Pavlovic, et al.Headache|April 18, 2015
Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) StudyDawn C Buse, Daniel Serrano, Michael L Reed, et al.Pageof 23